Research article · 1 Jan 2026
Conference abstractPublished 3 Jan 2018
Metabolomics as novel non-invasive diagnostic biomarkers of GI disorders
University Hospital Southampton NHS Foundation Trust, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Diagnosis of gastrointestinal disorders requires extensive and often invasive investigations including endoscopy a biopsies and places a heavy burden, both on healthcare resources, because of the cost and on the individual, in times of diseaserelated disability and poor quality of life. Recently, there has been increasing interest in non-invasive biomarkers to diagnose various gastrointestinal and liver disorders. There is growing scientific interest in the investigation of metabolomics and numbers of studies have focused on the utilization of non-invasive biomarkers in the diagnosis of GI disorder in particular inflammatory bowel disease. The development of sophisticated analytical techniques has enabled the study and interpretation of changes in the fecal and breath volatile organic metabolites (VOMs) and its correlation with the pathophysiological mechanisms in the gut. VOMs are the chemicals that are the products and intermediates of metabolism and may be altered in liver diseases. Changes in fecal VOMs should reflect GI disorders and could potentially provide diagnostic information about these conditions. Multiple studies reported the differences in VOM profiles of healthy controls vs. patients with liver and other GI disorders. VOM profiles have been used to segregate patients by disease activity and the type of disease. The correlation of VOMs with microbiota is interesting and supports the hypothesis of gut microbial dysbiosis in the etiology of GI disease. This provides an important platform to explore the role of dysbiosis in gut and other GI disease pathogenesis and development of novel therapeutic targets. In future, further understanding of fecal VOMs may lead to the development of a rapid and simple point of care diagnosis and monitoring of GI disorder.
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Gastrointestinal & Digestive System.
Case report · 11 Nov 2025
Bitter Guard: A Gut Wrenching Surprise
Research article · 18 Jun 2025
Ursodeoxycholic Acid Treatment of LPAC Presenting as Post Cholecystectomy Pain: Rationale and Design of a Randomised Trial
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Gastrointestinal & Digestive System
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Iftikhar Ahmed”